William Plunkett Selected Research

William Plunkett Research Topics

Disease

32	Neoplasms (Cancer) 11/2023 - 01/2002
30	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 02/2002
23	Leukemia 01/2021 - 02/2002
21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 02/2002
8	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 12/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2012 - 10/2003
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2014 - 10/2003
6	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2011 - 08/2006
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019 - 06/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 12/2019 - 08/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2014 - 10/2003
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 10/2005
2	Lung Neoplasms (Lung Cancer) 11/2017 - 01/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2016 - 08/2010
2	Residual Neoplasm 01/2016 - 03/2011
2	Adenocarcinoma 04/2014 - 09/2003
2	Blast Crisis (Blast Phase) 08/2012 - 02/2005
2	Lymphoma (Lymphomas) 06/2005 - 01/2002
1	Pancreatic Cyst 11/2019
1	Inflammation (Inflammations) 11/2019
1	Metaplasia 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Carcinogenesis 11/2019
1	Obesity 11/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Hyperbilirubinemia 11/2017
1	Exanthema (Rash) 11/2017
1	Hypersensitivity (Allergy) 11/2017
1	Disease Progression 02/2015
1	Hematologic Diseases (Blood Diseases) 02/2015
1	Diarrhea 06/2014
1	Genetic Translocation (Chromosomal Translocation) 04/2014

Drug/Important Bio-Agent (IBA)

17	fludarabineIBA 12/2021 - 01/2002
16	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 10/2002
15	Clofarabine (Clolar)FDA Link 01/2018 - 03/2003
14	NucleosidesIBA 01/2019 - 09/2002
13	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 01/2002
9	2'- cyano- 2'- deoxyarabinofuranosylcytosineIBA 12/2019 - 08/2005
8	Gemcitabine FDA Link 11/2014 - 02/2002
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2005
6	Rituximab (Mabthera)FDA Link 12/2021 - 06/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 02/2002
6	sapacitabineIBA 01/2018 - 01/2010
6	ProdrugsIBA 01/2018 - 02/2002
6	triphosphoric acid (triphosphate)IBA 03/2008 - 10/2002
5	Antineoplastic Agents (Antineoplastics)IBA 02/2010 - 05/2003
4	MicroRNAs (MicroRNA)IBA 12/2016 - 10/2007
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2013 - 12/2006
4	7-hydroxystaurosporine (UCN 01)IBA 05/2007 - 02/2002
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 05/2009
3	venetoclaxIBA 01/2022 - 01/2019
3	ibrutinibIBA 12/2021 - 01/2019
3	Arabinofuranosylcytosine TriphosphateIBA 01/2018 - 10/2002
3	Messenger RNA (mRNA)IBA 09/2013 - 10/2005
3	DNA-Activated Protein KinaseIBA 08/2011 - 01/2008
3	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 08/2010 - 05/2009
3	Cladribine FDA LinkGeneric 07/2006 - 10/2002
2	Apoptosis Regulatory ProteinsIBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2008
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019 - 12/2016
2	Purine NucleosidesIBA 01/2018 - 11/2017
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018 - 11/2017
2	Transaminases (Aminotransferases)IBA 11/2017 - 06/2014
2	Ligases (Synthetase)IBA 01/2016 - 04/2009
2	alvocidib (flavopiridol)IBA 02/2015 - 10/2005
2	HomoharringtonineIBA 04/2014 - 01/2011
2	bcr-abl Fusion ProteinsIBA 04/2014 - 11/2006
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2013 - 12/2003
2	DeoxycytidineIBA 08/2012 - 01/2010
2	NK314IBA 08/2011 - 05/2007
2	ChromatinIBA 12/2010 - 01/2008
2	rabacfosadineIBA 06/2009 - 05/2008
2	NucleotidesIBA 06/2009 - 05/2008
2	nelarabine (506U78)FDA Link 03/2008 - 11/2006
2	Alkylating AgentsIBA 09/2007 - 02/2002
2	Mitochondrial DNA (mtDNA)IBA 12/2006 - 09/2003
2	Free RadicalsIBA 09/2003 - 05/2003
1	CYC065IBA 01/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	obinutuzumabIBA 12/2021
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 01/2021
1	TrabectedinIBA 12/2019
1	fibroblast growth factor 21IBA 11/2019
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	Platinum Compounds (Compounds, Platinum)IBA 01/2018
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2017
1	Histone Deacetylase InhibitorsIBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	Arginine (L-Arginine)FDA Link 06/2015
1	Cyclin-Dependent Kinase 9IBA 02/2015
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2014
1	triciribine phosphateIBA 11/2013

Therapy/Procedure

20	Therapeutics 11/2023 - 02/2002
7	Drug Therapy (Chemotherapy) 01/2017 - 06/2005
2	Intravenous Infusions 02/2005 - 12/2003
1	Immunomodulation 12/2019
1	Injections 11/2019